NEW MANAGING DIRECTOR FOR PHARMACELSUS
Dr. Klaus Biemel has taken over the role of the Managing Director of Pharmacelsus GmbH (Member of GBA Group Pharma). Dr. Biemel has proven his management skills as an executive (COO) of Pharmacelsus from 2007 to 2018, and brings almost 20 years of experience in the field of ADMET, DMPK and bioanalysis.
He became an expert in the assessment and development of small molecules and therapeutic peptides entities, including the overseeing and directing of preclinical profiling and development operations.